COVID-19 in children and altered inflammatory responses

BACKGROUND The coronavirus disease (COVID-19) pandemic while affecting all age groups appears to be less severe in children. In this journal, we have international contributions relaying experiences from paediatricians across the world. Patients aged <18 years only account for 2% of severely affected patients. However, children can still be vectors if they are asymptomatic and shedding the virus. Dong et al. described a cohort of 2143 children with suspected infection. In 34%, infection was confirmed but there was little critical illness and one death. There appeared to be proportionally more severe illness in infants, a result that could have be confounded by concomitant bronchiolitis. Chen et al. and others have also shown that there is no evidence of vertical transmission in pregnant women, although this possibility may still exist. Possible reason for this disparity in severity between adults and children may relate to differences in receptors in the renin–angiotensin system (RAS) and altered inflammatory responses to pathogens.

[1]  E. Molloy,et al.  Neonatal sepsis: need for consensus definition, collaboration and core outcomes , 2020, Pediatric Research.

[2]  H. Yoon,et al.  Age-Associated Changes in the Vascular Renin-Angiotensin System in Mice , 2016, Oxidative medicine and cellular longevity.

[3]  Xiaoqing Lu,et al.  Possible causes for decreased susceptibility of children to coronavirus , 2020, Pediatric Research.

[4]  R. Hotchkiss,et al.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy , 2013, Nature Reviews Immunology.

[5]  Guangyou Duan,et al.  A prospective observational cohort study , 2016 .

[6]  Huixia Yang,et al.  Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records , 2020, The Lancet.

[7]  Mitchell R. Ladd,et al.  A Dynamic Variation of Pulmonary ACE2 Is Required to Modulate Neutrophilic Inflammation in Response to Pseudomonas aeruginosa Lung Infection in Mice , 2019, The Journal of Immunology.

[8]  D. Schwartz,et al.  An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. , 2020, Archives of pathology & laboratory medicine.

[9]  Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  T. van der Poll,et al.  Age-dependent differences in pulmonary host responses in ARDS: a prospective observational cohort study , 2019, Annals of Intensive Care.

[11]  Michael T. Bigham,et al.  The Influence of Developmental Age on the Early Transcriptomic Response of Children with Septic Shock , 2011, Molecular medicine.

[12]  J. Mikes,et al.  Stereotypic Immune System Development in Newborn Children , 2018, Cell.

[13]  Zhongyi Jiang,et al.  Epidemiology of COVID-19 Among Children in China , 2020, Pediatrics.

[14]  Yan Chen,et al.  Infants Born to Mothers With a New Coronavirus (COVID-19) , 2020, Frontiers in Pediatrics.

[15]  N. Shinomiya,et al.  An in vitro Shwartzman reaction‐like response is augmented age‐dependently in human peripheral blood mononuclear cells , 2006, Journal of leukocyte biology.

[16]  A. Singanayagam,et al.  Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? , 2020, The Lancet.

[17]  Zhongyi Jiang,et al.  Epidemiology of COVID-19 Among Children in China , 2020, Pediatrics.

[18]  Lei Zhang,et al.  Effects of angiotensin II type 1 receptor antagonist on rats with septic shock. , 2015, International journal of clinical and experimental medicine.

[19]  Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy , 2020, Pediatric Research.

[20]  A. Teixeira,et al.  The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research. , 2017, Current drug targets.

[21]  P. Mehta,et al.  COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.

[22]  J. Chiche,et al.  Timing and causes of death in septic shock , 2015, Annals of Intensive Care.

[23]  P. Gressens,et al.  Ontogeny of cytokine responses to PHA from birth to adulthood , 2019, Pediatric Research.

[24]  M. Martínez Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus , 2020, Antimicrobial Agents and Chemotherapy.

[25]  Sharon Einav,et al.  A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 , 2020, Journal of Critical Care.

[26]  H. Wong,et al.  Leukocyte subset-derived genomewide expression profiles in pediatric septic shock* , 2009, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.